List of Tables
Table 1. Global Rheumatology Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Disease Modifying Anti-rheumatic Drugs
Table 3. Key Players of Nonsteroidal Anti-inflammatory Drugs
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Uric Acid Drugs
Table 6. Key Players of Others
Table 7. Global Rheumatology Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Rheumatology Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Rheumatology Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Rheumatology Drugs Market Share by Regions (2016-2021)
Table 11. Global Rheumatology Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Rheumatology Drugs Market Share by Regions (2022-2027)
Table 13. Rheumatology Drugs Market Trends
Table 14. Rheumatology Drugs Market Drivers
Table 15. Rheumatology Drugs Market Challenges
Table 16. Rheumatology Drugs Market Restraints
Table 17. Global Rheumatology Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Rheumatology Drugs Market Share by Players (2016-2021)
Table 19. Global Top Rheumatology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatology Drugs as of 2020)
Table 20. Ranking of Global Top Rheumatology Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Rheumatology Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Rheumatology Drugs Product Solution and Service
Table 24. Date of Enter into Rheumatology Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Rheumatology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Rheumatology Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Rheumatology Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Rheumatology Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Rheumatology Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Rheumatology Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Rheumatology Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Rheumatology Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Rheumatology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Rheumatology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Rheumatology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Rheumatology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Rheumatology Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Rheumatology Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Rheumatology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Rheumatology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Rheumatology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Rheumatology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Rheumatology Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Rheumatology Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Rheumatology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Rheumatology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Rheumatology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Rheumatology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Rheumatology Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Rheumatology Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Rheumatology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Rheumatology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Rheumatology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Rheumatology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Rheumatology Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Rheumatology Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Rheumatology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Rheumatology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Rheumatology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Rheumatology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Rheumatology Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Rheumatology Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Takeda Pharmaceutical Company Details
Table 65. Takeda Pharmaceutical Business Overview
Table 66. Takeda Pharmaceutical Rheumatology Drugs Product
Table 67. Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2016-2021) & (US$ Million)
Table 68. Takeda Pharmaceutical Recent Development
Table 69. Sanofi Company Details
Table 70. Sanofi Business Overview
Table 71. Sanofi Rheumatology Drugs Product
Table 72. Sanofi Revenue in Rheumatology Drugs Business (2016-2021) & (US$ Million)
Table 73. Sanofi Recent Development
Table 74. Genentech Company Details
Table 75. Genentech Business Overview
Table 76. Genentech Rheumatology Drugs Product
Table 77. Genentech Revenue in Rheumatology Drugs Business (2016-2021) & (US$ Million)
Table 78. Genentech Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Rheumatology Drugs Product
Table 82. Novartis Revenue in Rheumatology Drugs Business (2016-2021) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Janssen Biotech Company Details
Table 85. Janssen Biotech Business Overview
Table 86. Janssen Biotech Rheumatology Drugs Product
Table 87. Janssen Biotech Revenue in Rheumatology Drugs Business (2016-2021) & (US$ Million)
Table 88. Janssen Biotech Recent Development
Table 89. Amgen Company Details
Table 90. Amgen Business Overview
Table 91. Amgen Rheumatology Drugs Product
Table 92. Amgen Revenue in Rheumatology Drugs Business (2016-2021) & (US$ Million)
Table 93. Amgen Recent Development
Table 94. AbbVie Company Details
Table 95. AbbVie Business Overview
Table 96. AbbVie Rheumatology Drugs Product
Table 97. AbbVie Revenue in Rheumatology Drugs Business (2016-2021) & (US$ Million)
Table 98. AbbVie Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Revenue in Rheumatology Drugs Business (2016-2021) & (US$ Million)
Table 102. Pfizer Recent Development
Table 103. Bristol-Myers Squibb Company Company Details
Table 104. Bristol-Myers Squibb Company Business Overview
Table 105. Bristol-Myers Squibb Company Rheumatology Drugs Product
Table 106. Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2016-2021) & (US$ Million)
Table 107. Bristol-Myers Squibb Company Recent Development
Table 108. Merck & Co. Company Details
Table 109. Merck & Co. Business Overview
Table 110. Merck & Co. Rheumatology Drugs Product
Table 111. Merck & Co. Revenue in Rheumatology Drugs Business (2016-2021) & (US$ Million)
Table 112. Merck & Co. Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rheumatology Drugs Market Share by Type: 2020 VS 2027
Figure 2. Disease Modifying Anti-rheumatic Drugs Features
Figure 3. Nonsteroidal Anti-inflammatory Drugs Features
Figure 4. Corticosteroids Features
Figure 5. Uric Acid Drugs Features
Figure 6. Others Features
Figure 7. Global Rheumatology Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Rheumatology Drugs Report Years Considered
Figure 12. Global Rheumatology Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Rheumatology Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Rheumatology Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global Rheumatology Drugs Market Share by Regions (2022-2027)
Figure 16. Global Rheumatology Drugs Market Share by Players in 2020
Figure 17. Global Top Rheumatology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatology Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Rheumatology Drugs Revenue in 2020
Figure 19. Global Rheumatology Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global Rheumatology Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Rheumatology Drugs Market Share by Type (2016-2027)
Figure 23. North America Rheumatology Drugs Market Share by Application (2016-2027)
Figure 24. North America Rheumatology Drugs Market Share by Country (2016-2027)
Figure 25. United States Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Rheumatology Drugs Market Share by Type (2016-2027)
Figure 29. Europe Rheumatology Drugs Market Share by Application (2016-2027)
Figure 30. Europe Rheumatology Drugs Market Share by Country (2016-2027)
Figure 31. Germany Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Rheumatology Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Rheumatology Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Rheumatology Drugs Market Share by Region (2016-2027)
Figure 41. China Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Rheumatology Drugs Market Share by Type (2016-2027)
Figure 49. Latin America Rheumatology Drugs Market Share by Application (2016-2027)
Figure 50. Latin America Rheumatology Drugs Market Share by Country (2016-2027)
Figure 51. Mexico Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Rheumatology Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Rheumatology Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Rheumatology Drugs Market Share by Country (2016-2027)
Figure 57. Turkey Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Rheumatology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Takeda Pharmaceutical Revenue Growth Rate in Rheumatology Drugs Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Rheumatology Drugs Business (2016-2021)
Figure 62. Genentech Revenue Growth Rate in Rheumatology Drugs Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Rheumatology Drugs Business (2016-2021)
Figure 64. Janssen Biotech Revenue Growth Rate in Rheumatology Drugs Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Rheumatology Drugs Business (2016-2021)
Figure 66. AbbVie Revenue Growth Rate in Rheumatology Drugs Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Rheumatology Drugs Business (2016-2021)
Figure 68. Bristol-Myers Squibb Company Revenue Growth Rate in Rheumatology Drugs Business (2016-2021)
Figure 69. Merck & Co. Revenue Growth Rate in Rheumatology Drugs Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

LIST OF FIGURE